Assignee profile:

LEMONEX INC.

City:

Seoul

Country:

South Korea

Published Applications:

13

Last publication date:

2024-02-08

Patent Grants:

13

Last grant date:

2024-11-12

Top Inventors for applications by LEMONEX INC.

These are the the leading inventors for applications assigned to LEMONEX INC.:

Recent patent applications by LEMONEX INC.

LEMONEX INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-02-08 ✅ Patent 12,138,346 granted on 2024-11-12
US20240041771A1
Human necessities

Physiologically active substance carrier

#2 | 2022-05-12 ✅ Patent 11,701,378 granted on 2023-07-18
US20220143068A1
Human necessities

RNA and nucleic acid carrier including the same

#3 | 2022-03-10 ✅ Patent 12,076,336 granted on 2024-09-03
US20220072027A1
Human necessities

Pharmaceutical composition for preventing or treating liver cancer

#4 | 2021-12-02 ✅ Patent 11,793,757 granted on 2023-10-24
US20210369614A1
Human necessities

Physiologically active substance carrier

#5 | 2021-07-29 ✅ Patent 12,234,458 granted on 2025-02-25
US20210230602A1
Chemistry; metallurgy

Composition for inhibiting CTGF expression

#6 | 2021-07-29 ✅ Patent 11,633,447 granted on 2023-04-25
US20210228670A1
Human necessities

Pharmaceutical composition and functional health food for preventing or treating macular degeneration

#7 | 2021-07-29 ✅ Patent 12,295,967 granted on 2025-05-13
US20210228607A1
Human necessities

Pharmaceutical composition for prevention or treatment of flavivirus infection

#8 | 2021-06-17 ✅ Patent 12,343,406 granted on 2025-07-01
US20210177988A1
Human necessities

IMMUNOREACTANT CARRIER

#9 | 2021-05-13 ✅ Patent 11,779,582 granted on 2023-10-10
US20210137922A1
Human necessities

Composition for preventing or treating metastatic ovarian cancer, endometrial cancer or breast cancer

#10 | 2020-01-09 ✅ Patent 11,129,796 granted on 2021-09-28
US20200009054A1
Human necessities

Physiologically active substance carrier

#11 | 2019-03-07 ✅ Patent 11,530,132 granted on 2022-12-20
US20190071314A1
Chemistry; metallurgy

Composition comprising porous silica particles carrying a cell fate modulating factor

#12 | 2018-10-25 ✅ Patent 10,809,196 granted on 2020-10-20
US20180306718A1
Physics

Quencher containing water soluble polymer-conjugated nanomaterial and use thereof

#13 | 2017-06-22 ✅ Patent 11,786,469 granted on 2023-10-17
US20170172923A1
Human necessities

Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasome

Also check out LEMONEX INC.'s (Seoul, South Korea) applicant profile with 15 patent applications submitted.

AssigneeID:

391853 ⎘